PHSE
Pharmhouse Corp
0.0096$
+6.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -29.0% | +445.3% | -18.0% | +83.9% | -13.4% | -32.8% | +5,033.0% | +183.0% | +4.7% | -14.8% | |
| – | – | -98.5% | +14,597.1% | -74.1% | +411.6% | -33.3% | -87.1% | +1,538.2% | +1,872.5% | +28.3% | -70.9% | |
| – | – | -98.5% | +14,597.1% | -74.1% | +411.6% | -33.3% | -87.1% | +252.6% | +103.7% | -80.8% | +80.9% | |
| – | – | -98.5% | +14,597.1% | -74.1% | +411.6% | -33.3% | -87.1% | +252.6% | +103.7% | -80.8% | +80.9% | |
| – | – | – | – | – | – | – | – | – | +37.3% | -25.2% | +0.0% | |
| – | – | – | – | – | – | – | – | – | -23.6% | -37.6% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | |
| – | – | – | +131.1% | +61.2% | -5.7% | +0.0% | +0.0% | – | – | -0.8% | -0.8% | |
| – | – | +32.3% | +93.5% | +4.6% | +78.8% | +7.5% | +49.9% | -23.4% | +279.6% | +2.2% | -9.8% | |
| – | – | +32.3% | +93.5% | +4.6% | +78.8% | +7.5% | +49.9% | -23.4% | +271.3% | +2.3% | -10.0% | |
| – | – | +30.0% | +93.4% | +0.0% | +61.8% | +0.0% | -5.3% | +21.1% | +188.7% | +7.7% | -10.7% | |
| – | – | – | – | – | – | – | – | – | +471.3% | +69.8% | +27.5% | |
| – | – | – | – | – | – | – | – | – | +172.3% | +5.0% | -15.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +46.3% | +304.0% | +1.1% | +0.3% | +0.0% | +0.0% | +1.1% | +76.0% | +1.1% | +44.3% | +3.2% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.